Microbial Metabolism of Inflammatory Bowel Disease Drugs: Current Evidence and Clinical Implementations

Gastroenterology. 2022 Jan;162(1):4-8. doi: 10.1053/j.gastro.2021.07.050. Epub 2021 Sep 8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / metabolism
  • Anti-Inflammatory Agents / therapeutic use*
  • Bacteria / metabolism*
  • Biotransformation
  • Disease Models, Animal
  • Gastrointestinal Microbiome*
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / metabolism
  • Immunosuppressive Agents / therapeutic use*
  • Inflammatory Bowel Diseases / drug therapy*
  • Inflammatory Bowel Diseases / immunology
  • Inflammatory Bowel Diseases / microbiology

Substances

  • Anti-Inflammatory Agents
  • Immunosuppressive Agents